xCystence Bio Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 5

xCystence Bio General Information

Description

Developer of polycystic kidney disease therapeutics designed to prevent the formation of new cysts and the growth of existing ones. The company's technology identifies and blocks a specific cell signaling pathway active in genetic kidney disease to prevent and slow down the progression, enabling the healthcare sector to slow disease progression and improve patient quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Melbourne, Victoria
  • Australia
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Melbourne, Victoria
  • Australia

xCystence Bio Timeline

202420252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

xCystence Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 30-Mar-2026 Completed Pre-Clinical Trials
3. Grant 04-Sep-2025 Completed Pre-Clinical Trials
2. Accelerator/Incubator 05-Jun-2023 $500K $500K Completed Pre-Clinical Trials
1. University Spin-Out 06-Apr-2023 Completed Pre-Clinical Trials
To view xCystence Bio’s complete valuation and funding history, request access »

xCystence Bio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioCurate University Minority
Breakthrough Victoria Venture Capital Minority
Uniseed Venture Capital Minority
Brandon Biocatalyst Venture Capital Minority
Monash University University Minority
To view xCystence Bio’s complete investors history, request access »

xCystence Bio FAQs

  • When was xCystence Bio founded?

    xCystence Bio was founded in 2023.

  • Where is xCystence Bio headquartered?

    xCystence Bio is headquartered in Melbourne, Australia.

  • What industry is xCystence Bio in?

    xCystence Bio’s primary industry is Drug Discovery.

  • Is xCystence Bio a private or public company?

    xCystence Bio is a Private company.

  • What is xCystence Bio’s current revenue?

    The current revenue for xCystence Bio is .

  • How much funding has xCystence Bio raised over time?

    xCystence Bio has raised $500K.

  • Who are xCystence Bio’s investors?

    BioCurate, Breakthrough Victoria, Uniseed, Brandon Biocatalyst, and Monash University have invested in xCystence Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process